Lenvacent

Lenvacent uses and dosage

Lenvacent (Lenvatinib), generic Lenvima is a prescription medicine used to treat recurrent or metastatic, progressive, radioactive iodine-refractory differentiated thyroid cancer, advanced renal cell carcinoma (RCC), hepatocellular carcinoma (HCC). Lenvacent manufactured by Incepta Pharma Ltd. in Bangladesh. Lenvatinib has to take orally once a day with or without food.

Lenvacent side effects

The most common adverse reactions of Lenvatinib are: Dry mouth, hoarseness, nose bleeds, tiredness, weight loss, headache, muscle/ joint pain, trouble sleeping, change in taste, diarrhea, constipation, upset stomach, nausea, vomiting, or loss of appetite.

Originator brand

Lenvima by Eisai Inc

Made by

Incepta Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.